Micro-X Ltd. · ASX:MX1
Micro-X — Shareholder Meeting (November 2022)
40 slides from Micro-X's shareholder meeting presentation, Nov 14, 2022
Slide 1: Primed for Growth – 2022 Annual General Meeting
ACN 153 273 735 / ASX: MX1 PRIMED FOR GROWTH 2022 Annual General Meeting 14 November 2022 1pm Adelaide time A14 6 MAB Eastern Promenade, Tonsley, South Australia Attend online via https://us02web.zoom.us/webinar/register/WN_sgwBZWJ3Rh qjVMotv3ECdg
Slide 2: Acknowledgement of Country
A C K N O W L E D G E M E N T O F C O U N T R Y Micro-X acknowledges the Traditional Owners of Country throughout Australia, including the Kaurna people on whose land we meet today. We pay our respects to Elders past and present. 2
Slide 3: Agenda – 2022 Annual General Meeting
A G E N D A 2022 Annual General Meeting Acknowledgement of Country Open meeting Chair’s address CEO presentation AGM resolutions Q&A Close meeting Tour of Tonsley facility Details for virtual attendees Annual General Meeting will be held virtually on the online platform, Zoom webinar at https://us02
Slide 4: Chair's Address
MICRO-X CHAIR’S ADDRESS
Slide 5: CEO Presentation
ACN 153 273 735 / ASX: MX1 PRIMED FOR GROWTH 2022 Annual General Meeting CEO presentation Peter Rowland Managing Director & CEO
Slide 6: Miniaturising X-ray
M I N I A T U R I S I N G X - R A Y First mover in Nano Electronic X-ray (NEX) Technology for global health and security markets 6
Slide 7: Financial Highlights FY22
F I N A N C I A L H I G H L I G H T S F Y 2 0 2 2 Foundations for future growth across all four products Revenue $9.0M ↑ 138% (FY21 $3.8M) Secured major contracts1 AUD$14M Other income $4.1M ↑ 38% (FY21 $3.0M) DHS US$4M + ASA AUD$8M Mobile DR sales $3.8M (FY21 $3.6M) Costs reduced & realigned ↓22% F
Slide 8: FY2022 Operational Highlights
F Y 2 0 2 2 O P E R A T I O N A L H I G H L I G H T S Strong commercial progress and key developmental milestones achieved Mobile DR - Rover IED Camera - Argus Checkpoints Brain CT Scanner ü Major brand launch at RSNA ü Successful test images with 160kV ü DHS accepted design for ü $8M ASA contract s
Slide 9: Tube Development
T U B E D E V E L O P M E N T Three different tubes, all using NEX technology 1 2 3 1 First generation NEX tube - developed in 2018 - sold commercially in Mobile DR products 2 Reverse polarity NEX tube – developed in 2021-22 – in Argus IED camera and CT Baggage Scanner from 2023 3 Miniature NEX tube
Slide 10: Generator Development
G E N E R A T O R D E V E L O P M E N T World-leading innovation in high voltage power supplies In-house design and manufacture of high-voltage generators optimises product design, means we can better control manufacturing costs and reduces reliance on overseas suppliers Expansion of core technology
Slide 11: Imaging Software
I M A G I N G S O F T W A R E Common image reconstruction and processing techniques supports products Rover – 2D imaging Argus – 2D imaging using backscatter CT Baggage Scanner & Brain CT Scanner – 3D imaging - engineers in Adelaide and Seattle developing algorithms and software Argus – integrated s
Slide 12: Varex Strategic Collaboration
V A R E X S T R A T E G I C C O L L A B O R A T I O N $15M technology collaboration and investment by Varex Imaging Technology collaboration strongly validates Micro-X NEX technology o Collaborating with a leading innovator and manufacturer of x-ray tubes & detectors o Builds greater acceptance and
Slide 13: One Company, Four Businesses
ONE COMPANY, FOUR BUSINESSES T h e p o w e r o f M i c r o - X N E X T e c h n o l o g y
Slide 14: Mobile DR
M O B I L E D R Launch of Rover Plus and expanded US distribution network First tier mobile X-ray unit - 100kg v 600kg Proven versatility in a range of uses o Medical – Military – Veterinary – In-home High quality & reliability – industry leading ‘tubes for life’ Next gen Rover Plus – higher x-ray p
Slide 15: Mobile DR – Saving lives and simplifying workflow
M O B I L E D R Saving lives and simplifying workflow for health professionals “The availability of mobile x-ray units with a built-in battery (in connection with the regular shelling of Ukraine’s energy infrastructure) is currently among the needs to ensure a quick examination of wounded persons… T
Slide 16: IED X-ray Camera – Argus
I E D X - R A Y C A M E R A – A R G U S Saving lives in the world’s most dangerous workplace Remote viewing with Argus camera carried by EOD robot Vastly lower risk to technician – robot can perform assessment as well as disrupt device remotely High resolution image allows diagnosis to component lev
Slide 17: Argus Progress
A R G U S P R O G R E S S Product development being completed, customer trials 2023 Key components designed, built and tested Technical refinements for a robust, production o Reverse polarity 160kV x-ray tube – smaller than Rover product o High-voltage generator - miniaturised o New processes in hig
Slide 18: Checkpoints
C H E C K P O I N T S Transforming the future of air travel – speed, safety, privacy Market opportunity is US$24B in airports alone Customer driven concept to improve travel experience US$8B in US airports and US$16B in ROW airports Automation will improve experience - faster TSA annual manpower cos
Slide 19: Checkpoints – DHS contracts
C H E C K P O I N T S Funded by two contracts with Department of Homeland Security – US$4.5M CT Baggage Scanner Passenger Self Screening Portal - US$2M contract for prototype mid 2023 - US$2.5M contract for design completes 2023 3D imaging of passenger carry-on luggage Self service portal for entire
Slide 20: Passenger Self-Screening Checkpoint
P A S S E N G E R S E L F - S C R E E N I N G C H E C K P O I N T 20 https://youtu.be/NX9gZgZiSOk
Slide 21: Brain CT Scanner
B R A I N C T S C A N N E R Programme on time & on budget - commercial product in 3 years Micro-X CT Scanner supported by $8M from Commonwealth MRFF Fund in partnership with Australian Stroke Alliance Robust imager with no moving parts Designed to image bleeds smaller than 1mm ‘Standard of Care’ CT
Slide 22: Environment, Social & Governance
E N V I R O N M E N T , S O C I A L & G O V E R N A N C E Our people and culture are the key to our ongoing innovation & success 23% female employees and 0 Lost time injuries since Dec 2020 Partnered with Non-Government 18 nationalities represented Zero fatalities or serious injuries Organisations t
Slide 23: Outlook for FY23 – Primed for Growth
O U T L O O K F O R 2 0 2 3 Primed for growth Argus x-ray camera first sales o Successful customer demonstrations o Australian DoD LAND 154 tender decision o First sales of Argus systems CT Baggage Scanner prototypes delivered to DHS Self-Screening Checkpoint design completion Mobile DR growth in pi
Slide 24: Important Notice
IMPORTANT NOTICE S C O P E & L I M I TAT I O N S This Presentation has been prepared by Micro-X Limited (Micro-X or the Company) (ASX.MX1). The Presentation is a summary only and does not contain all the information about the Company’s assets and liabilities, financial position and performance, prof
Slide 25: Ordinary Business
MICRO-X ORDINARY BUSINESS
Slide 26: AGM Items of Business
A G M - O R D I N A R Y B U S I N E S S Items of business 2022 Financial Statements and Reports Resolution 1: Adoption of Remuneration Report Resolution 2: Re-election of Ms Ilona Meyer as a Director of the Company Resolution 3: Re-election of Mr Andrew Hartmann as a Director of the Company - WITHDR
Slide 27: 2022 Financial Statements and Reports
O R D I N A R Y B U S I N E S S 2022 Financial Statements and Reports While not a requirement that shareholders vote in relation to the accounts, we are pleased to answer any questions you may have relating to them. 27
Slide 28: Resolution 1 – Adoption of Remuneration Report
O R D I N A R Y B U S I N E S S Resolution 1 - Adoption of Remuneration Report To consider and, if thought fit, to pass the following resolution as an ordinary resolution: “That for the purpose of Section 250R(2) of the Corporations Act and for all other purposes, the Remuneration Report (included i
Slide 29: Resolution 2 – Re-election of Ilona Meyer
O R D I N A R Y B U S I N E S S Resolution 2 - Re-election of Ms Ilona Meyer as a Director of the Company To consider and, if thought fit, to pass the following resolution as an ordinary resolution: “That Ms Ilona Meyer, being a Director who was appointed by the Company's Directors on 7 March 2022 p
Slide 30: Resolution 4 – Ratification of Tranche A Placement Shares
O R D I N A R Y B U S I N E S S Resolution 4 - Ratification of issue of the Tranche A Placement Shares To consider and, if thought fit, to pass the following resolution as an ordinary resolution: "That, for the purposes of ASX Listing Rule 7.4 and for all other purposes, Shareholders ratify the issu
Slide 31: Resolution 5 – Ratification of Tranche B Placement Shares
O R D I N A R Y B U S I N E S S Resolution 5 - Ratification of issue of the Tranche B Placement Shares To consider and, if thought fit, to pass the following resolution as an ordinary resolution: "That, for the purposes of ASX Listing Rule 7.4 and for all other purposes, Shareholders ratify the agre
Slide 32: Resolution 6 – Performance Rights to Ilona Meyer
O R D I N A R Y B U S I N E S S Resolution 6 - Approval of issue of Performance Rights to Ms Ilona Meyer under the Employee Equity Plan To consider and, if thought fit, to pass the following resolution as an ordinary resolution: "That, for the purposes of ASX Listing Rule 10.14, sections 200B and 20
Slide 33: Resolution 7 – Shares to David Knox in Lieu of Fees
O R D I N A R Y B U S I N E S S Resolution 7 - Approval of issue of Shares to Mr David Knox in Lieu of Cash Payments for Directors' Fees To consider and, if thought fit, to pass the following resolution as an ordinary resolution: “That, pursuant to and in accordance with ASX Listing Rule 10.11 and f
Slide 34: Resolution 8 – Shares to Patrick O'Brien in Lieu of Fees
O R D I N A R Y B U S I N E S S Resolution 8 - Approval of issue of Shares to Mr Patrick O'Brien in Lieu of Cash Payments for Directors' Fees To consider and, if thought fit, to pass the following resolution as an ordinary resolution: “That, pursuant to and in accordance with ASX Listing Rule 10.11
Slide 35: Resolution 9 – Shares to Alexander Gosling in Lieu of Fees
O R D I N A R Y B U S I N E S S Resolution 9 - Approval of issue of Shares to Dr Alexander Gosling in Lieu of Cash Payments for Directors' Fees To consider and, if thought fit, to pass the following resolution as an ordinary resolution: “That, pursuant to and in accordance with ASX Listing Rule 10.1
Slide 36: Resolution 10 – Shares to James McDowell in Lieu of Fees
O R D I N A R Y B U S I N E S S Resolution 10 - Approval of issue of Shares to Mr James McDowell in Lieu of Cash Payments for Directors' Fees To consider and, if thought fit, to pass the following resolution as an ordinary resolution: “That, pursuant to and in accordance with ASX Listing Rule 10.11
Slide 37: Resolution 11 – Shares to Ilona Meyer in Lieu of Fees
O R D I N A R Y B U S I N E S S Resolution 11 - Approval of issue of Shares to Ms Ilona Meyer in Lieu of Cash Payments for Directors' Fees To consider and, if thought fit, to pass the following resolution as an ordinary resolution: “That, pursuant to and in accordance with ASX Listing Rule 10.11 and
Slide 38: General Questions
O R D I N A R Y B U S I N E S S General questions Please lodge questions via Zoom or ask your question on the roving microphone 38
Slide 39: Please Finalise Your Voting
O R D I N A R Y B U S I N E S S Please finalise your voting
Slide 40: Thank You
MICRO-x THANK YOU